Artemisinin reduces the level of antibodies to gliadin in schizophrenia

The study did not demonstrate clinical benefit of adjunctive artemisinin for schizophrenia symptoms. The finding of reduced levels of antibodies to gliadin in the artemisinin group merits further study.